Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT
Oncolytics Biotech Income Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 123K | 107K | 103K | 96K | 97K | 99.01K | 97.82K | 97.61K | 97.56K | 96.97K | 84.52K | 163.83K | 106.73K |
Gross Profit | n/a | n/a | n/a | -98K | -123K | -107K | -103K | -96K | -97K | -99.01K | -97.82K | -97.61K | -97.56K | -96.97K | -84.52K | -163.83K | -106.73K |
Operating Income | -7M | n/a | -9.9M | -7.92M | -8.73M | -8.85M | -11.05M | -7.16M | -6.73M | -8.2M | -6.06M | -6.97M | -6.31M | -7.45M | -6.16M | -6.72M | -5.9M |
Interest Income | 123K | 152K | 261K | 340K | 446K | 489K | 305K | 267K | 265K | 313.75K | 146K | 49K | 18K | 22.16K | 25.74K | 29.22K | 21.49K |
Pretax Income | -6.69M | -7.99M | -9.53M | -7.16M | -6.89M | -3.91M | -9.92M | -7.39M | -6.44M | -8.5M | -4.4M | -5.07M | -6.78M | -7.71M | -4.86M | -7.25M | -6.43M |
Net Income | -6.69M | -8.02M | -9.54M | -7.26M | -6.89M | -3.95M | -9.93M | -7.44M | -6.11M | -8.55M | -4.41M | -5.09M | -7.72M | -7.75M | -4.87M | -7.25M | -6.43M |
Selling & General & Admin | 2.82M | 3.46M | 3.1M | 3.36M | 2.86M | 4.08M | 5.13M | 3.36M | 3.19M | 3.67M | 2.38M | 2.74M | 2.6M | 3.68M | 2.79M | 3.36M | 3.04M |
Research & Development | 4.08M | 4.55M | 6.79M | 4.56M | 5.74M | 4.66M | 5.81M | 3.7M | 3.54M | 4.84M | 3.68M | 3.2M | 3.71M | 3.68M | 3.28M | 3.2M | 2.76M |
Other Expenses | 97K | 424K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.84M | 2.6M | 3.78M | 2.88M | 3.52M | 3.14M |
Operating Expenses | 7M | 8.44M | 9.9M | 7.92M | 8.6M | 8.74M | 11.05M | 7.16M | 6.73M | 8.51M | 6.06M | 6.05M | 6.31M | 7.45M | 6.16M | 6.72M | 5.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.67M | -84.52K | n/a | n/a |
Cost & Expenses | 7M | 8.44M | 9.9M | 7.92M | 8.73M | 8.85M | 11.05M | 7.16M | 6.73M | 8.51M | 6.06M | 6.05M | 6.31M | 7.45M | 6.16M | 6.72M | 5.9M |
Income Tax Expense | n/a | 23K | 12K | 95K | n/a | 43K | 7K | 47K | -329K | 56.58K | 2.6K | 24.82K | 936.87K | 42.28K | 7.15K | n/a | n/a |
Shares Outstanding (Basic) | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M | 49.67M |
Shares Outstanding (Diluted) | 84.63M | 76.09M | 77.02M | 76.09M | 75.24M | 73.73M | 69.8M | 64.47M | 62.34M | 59.51M | 58.33M | 57.67M | 56.58M | 54.96M | 54.96M | 54.33M | 49.67M |
EPS (Basic) | -0.08 | -0.11 | -0.12 | -0.1 | -0.09 | -0.05 | -0.14 | -0.12 | -0.1 | -0.14 | -0.08 | -0.09 | -0.14 | -0.14 | -0.09 | -0.13 | -0.13 |
EPS (Diluted) | -0.08 | -0.11 | -0.12 | -0.1 | -0.09 | -0.05 | -0.14 | -0.12 | -0.1 | -0.14 | -0.08 | -0.09 | -0.14 | -0.14 | -0.09 | -0.13 | -0.13 |
EBITDA | -6.9M | -8.34M | -9.79M | -7.92M | -8.6M | -8.74M | -10.95M | -7.06M | -6.64M | -8.49M | -5.96M | -6.02M | -6.21M | -7.36M | -6.07M | -6.65M | -5.79M |
EBIT | -7M | -8.44M | -9.9M | -7.92M | -8.73M | -8.85M | -11.05M | -7.16M | -6.73M | -8.51M | -6.06M | -6.05M | -6.31M | -7.45M | -6.16M | -6.72M | -5.9M |
Depreciation & Amortization | 97K | 98K | 105K | n/a | 123K | 107K | 103K | 96K | 97K | 99.01K | 97.82K | 97.61K | 97.56K | 96.97K | 84.52K | 163.83K | 106.73K |